SOPH · ISSUER CIK 1840706
SOPHiA GENETICS SA
Between Aug 1, 2026 and Oct 29, 2026, 10 SOPHiA GENETICS SA insiders reported $0.00 of open-market purchases and $2.3M of sales on SEC Form 4.
↗10 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 32 of 33 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$2.3MInsider selling
−$2.3MNet open-market
Oct 14, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 202616:04 | Oct 12, 2026 | SOPH | Chief Medical Officer | S · Sell10b5-1 | $7.26 | −5,000 | 195,993 | -2% | −$36K | ||
| Oct 14, 202616:03 | Oct 13, 2026 | SOPH | Chief Scientific Officer | S · Sell10b5-1 | $7.18 | −4,000 | 541,493 | -1% | −$29K | ||
| Oct 14, 202616:02 | Oct 12, 2026 | SOPH | Executive Chairman, Director | S · Sell10b5-1 | $7.26 | −8,500 | 3,387,150 | -0% | −$62K | ||
| Oct 7, 202616:04 | Oct 5, 2026 | SOPH | Chief Legal Officer | S · Sell10b5-1 | $8.12 | −6,168 | 332,716 | -2% | −$50K | ||
| Oct 7, 202616:04 | Oct 5, 2026 | SOPH | Chief People Officer | S · Sell10b5-1 | $8.13 | −4,240 | 206,210 | -2% | −$34K | ||
| Oct 7, 202616:04 | Oct 5, 2026 | SOPH | Chief Technology Officer | S · Sell10b5-1 | $8.12 | −5,284 | 166,887 | -3% | −$43K | ||
| Oct 7, 202616:04 | Oct 5, 2026 | SOPH | Chief Sales Officer | S · Sell | $8.04 | −216 | 147,732 | -0% | −$2K | ||
| Oct 7, 202616:04 | Oct 5, 2026 | SOPH | Chief Financial Officer | S · Sell10b5-1 | $8.10 | −1,592 | 306,726 | -1% | −$13K | ||
| Oct 7, 202616:04 | Oct 5, 2026 | SOPH | Chief Medical Officer | S · Sell10b5-1 | $8.13 | −7,394 | 200,993 | -4% | −$60K | ||
| Oct 7, 202616:04 | Oct 5, 2026 | SOPH | Executive Chairman, Director | S · Sell10b5-1 | $8.13 | −40,172 | 3,395,650 | -1% | −$327K | ||
| Oct 7, 202616:04 | Oct 5, 2026 | SOPH | Chief Scientific Officer | S · Sell10b5-1 | $8.12 | −7,394 | 545,493 | -1% | −$60K | ||
| Oct 7, 202616:03 | Oct 5, 2026 | SOPH | Chief Executive Officer, Director | S · Sell10b5-1 | $8.13 | −9,838 | 660,391 | -1% | −$80K | ||
| Sep 22, 202616:02 | Sep 21, 2026 | SOPH | Chief Financial Officer | S · Sell10b5-1 | $8.33 | −774 | 308,318 | -0% | −$6K | ||
| Sep 22, 202616:02 | Sep 21, 2026 | SOPH | Chief Executive Officer, Director | S · Sell10b5-1 | $8.33 | −422 | 670,229 | -0% | −$4K | ||
| Sep 16, 202616:01 | Sep 14, 2026 | SOPH | Chief Medical Officer | S · Sell10b5-1 | $7.88 | −5,000 | 208,387 | -2% | −$39K | ||
| Sep 16, 202616:01 | Sep 14, 2026 | SOPH | Chief Scientific Officer | S · Sell10b5-1 | $7.88 | −4,000 | 552,887 | -1% | −$32K | ||
| Sep 14, 202616:01 | Sep 11, 2026 | SOPH | Chief Legal Officer | S · Sell10b5-1 | $7.63 | −6,168 | 338,884 | -2% | −$47K | ||
| Sep 14, 202616:01 | Sep 10, 2026 | SOPH | Executive Chairman, Director | S · Sell10b5-1 | $7.66 | −8,500 | 3,435,822 | -0% | −$65K | ||
| Sep 10, 202616:02 | Sep 8, 2026 | SOPH | Director | S · Sell10b5-1 | $8.13 | −6,250 | 96,992 | -6% | −$51K | ||
| Aug 31, 202616:02 | Aug 27, 2026 | SOPH | Chief Scientific Officer | S · Sell10b5-1 | $8.91 | −10,000 | 556,887 | -2% | −$89K | ||
| Aug 26, 202616:04 | Aug 25, 2026 | SOPH | Chief Medical Officer | S · Sell10b5-1 | $8.68 | −5,000 | 213,387 | -2% | −$43K | ||
| Aug 26, 202616:04 | Aug 25, 2026 | SOPH | Director | S · Sell10b5-1 | $8.68 | −6,250 | 103,242 | -6% | −$54K | ||
| Aug 26, 202616:03 | Aug 24, 2026from Aug 19, 2026 | SOPH | Chief Technology Officer | S · Sell10b5-1 | $8.50 | −10,000 | 172,171 | -5% | −$85K | ||
| Aug 21, 202616:02 | Aug 19, 2026 | SOPH | Chief People Officer | S · Sell10b5-1 | $7.94 | −10,000 | 210,450 | -5% | −$79K | ||
| Aug 21, 202616:02 | Aug 19, 2026 | SOPH | Chief People Officer | M · Exercise10b5-1 | $3.20 | +10,000 | 220,450 | +5% | $32K | ||
| Aug 21, 202616:01 | Aug 21, 2026from Aug 19, 2026 | SOPH | Chief Scientific Officer | S · Sell10b5-1 | $8.17 | −20,000 | 566,887 | -3% | −$163K | ||
| Aug 14, 202616:40 | Aug 12, 2026 | SOPH | Chief Medical Officer | S · Sell10b5-1 | $7.52 | −5,000 | 218,387 | -2% | −$38K | ||
| Aug 14, 202616:40 | Aug 13, 2026 | SOPH | Chief Scientific Officer | S · Sell10b5-1 | $7.52 | −4,000 | 586,887 | -1% | −$30K | ||
| Aug 10, 202617:14 | Aug 7, 2026 | SOPH | Chief Technology Officer | S · Sell10b5-1 | $7.60 | −5,000 | 182,171 | -3% | −$38K | ||
| Aug 10, 202617:14 | Aug 10, 2026from Aug 7, 2026 | SOPH | Executive Chairman, Director | S · Sell10b5-1 | $7.34 | −28,500 | 3,444,322 | -1% | −$209K | ||
| Aug 7, 202617:35 | Aug 7, 2026from Aug 5, 2026 | SOPH | Chief Scientific Officer | S · Sell10b5-1 | $7.25 | −20,000 | 590,887 | -3% | −$145K | ||
| Aug 7, 202617:35 | Aug 7, 2026from Aug 5, 2026 | SOPH | Chief Scientific Officer | M · Exercise10b5-1 | $3.28 | +10,000 | 607,887 | +2% | $33K | ||
| Aug 5, 202616:14 | Aug 4, 2026 | SOPH | Chief Technology Officer | S · Sell10b5-1 | $6.95 | −5,000 | 187,171 | -3% | −$35K | ||
| Aug 5, 202616:14 | Aug 4, 2026 | SOPH | Executive Chairman, Director | S · Sell10b5-1 | $6.92 | −20,000 | 3,472,822 | -1% | −$138K | ||
| Aug 5, 202616:13 | Aug 4, 2026 | SOPH | Chief Scientific Officer | S · Sell10b5-1 | $6.92 | −10,000 | 600,887 | -2% | −$69K |